153 related articles for article (PubMed ID: 29454167)
41. Decursin from Angelica gigas Nakai Inhibits B16F10 Melanoma Growth Through Induction of Apoptosis.
Kim BS; Seo H; Kim HJ; Bae SM; Son HN; Lee YJ; Ryu S; Park RW; Nam JO
J Med Food; 2015 Oct; 18(10):1121-7. PubMed ID: 26336081
[TBL] [Abstract][Full Text] [Related]
42. The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related Caspase Pathway.
Li L; Du J; Zou L; Xia H; Wu T; Kim Y; Lee Y
Neurochem Res; 2015 Aug; 40(8):1555-62. PubMed ID: 26077922
[TBL] [Abstract][Full Text] [Related]
43. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.
Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY
Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925
[TBL] [Abstract][Full Text] [Related]
44. Bio- Fortification of
Azad MOK; Kang WS; Lim JD; Park CH
Pharmaceuticals (Basel); 2019 Dec; 13(1):. PubMed ID: 31881704
[No Abstract] [Full Text] [Related]
45. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
[TBL] [Abstract][Full Text] [Related]
46. Decursinol from Angelica gigas Nakai enhances endometrial receptivity during implantation.
Kim SE; Lee JE; Han YH; Lee SI; Kim DK; Park SR; Yu SL; Kang J
BMC Complement Med Ther; 2020 Feb; 20(1):36. PubMed ID: 32024510
[TBL] [Abstract][Full Text] [Related]
47. Development and validation of an ultra-performance convergence chromatography method for the quality control of Angelica gigas Nakai.
Kim HS; Chun JM; Kwon BI; Lee AR; Kim HK; Lee AY
J Sep Sci; 2016 Oct; 39(20):4035-4041. PubMed ID: 27510737
[TBL] [Abstract][Full Text] [Related]
48. Improvement of Fatigue Symptoms and Endurance Capacity by the Combined Administration of
Huang WY; Youk JS; Han BK; Heo W; Yun BS; Kim JS; Koo YT; Hwang KA; Yoon JA; Kim YJ
J Med Food; 2021 Jun; 24(6):577-585. PubMed ID: 34161165
[TBL] [Abstract][Full Text] [Related]
49. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.
Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J
PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490
[TBL] [Abstract][Full Text] [Related]
50. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi.
Lee HW; Ryu HW; Kang MG; Park D; Lee H; Shin HM; Oh SR; Kim H
Int J Biol Macromol; 2017 Apr; 97():598-605. PubMed ID: 28109809
[TBL] [Abstract][Full Text] [Related]
51. Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.
Choi KO; Lee I; Paik SY; Kim DE; Lim JD; Kang WS; Ko S
J Med Food; 2012 Oct; 15(10):863-72. PubMed ID: 23039111
[TBL] [Abstract][Full Text] [Related]
52. Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas.
Yoo HH; Lee MW; Kim YC; Yun CH; Kim DH
Drug Metab Dispos; 2007 Oct; 35(10):1759-65. PubMed ID: 17620343
[TBL] [Abstract][Full Text] [Related]
53. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
54. HER2 Targeted Breast Cancer Therapy with Switchable "Off/On" Multifunctional "Smart" Magnetic Polymer Core-Shell Nanocomposites.
Vivek R; Thangam R; Kumar SR; Rejeeth C; Kumar GS; Sivasubramanian S; Vincent S; Gopi D; Kannan S
ACS Appl Mater Interfaces; 2016 Jan; 8(3):2262-79. PubMed ID: 26771508
[TBL] [Abstract][Full Text] [Related]
55. Far Infrared Irradiation Enhances Nutraceutical Compounds and Antioxidant Properties in Angelica gigas Nakai Powder.
Azad MOK; Piao JP; Park CH; Cho DH
Antioxidants (Basel); 2018 Dec; 7(12):. PubMed ID: 30545026
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.
Song JS; Chae JW; Lee KR; Lee BH; Choi EJ; Ahn SH; Kwon KI; Bae MA
Xenobiotica; 2011 Oct; 41(10):895-902. PubMed ID: 21657833
[TBL] [Abstract][Full Text] [Related]
57. Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.
Shiomi K; Hatano H; Morimoto H; Ui H; Sakamoto K; Kita K; Tomoda H; Lee EW; Heo TR; Kawagishi H; Omura S
Planta Med; 2007 Nov; 73(14):1478-81. PubMed ID: 17948169
[TBL] [Abstract][Full Text] [Related]
58. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
[TBL] [Abstract][Full Text] [Related]
59. Analysis and Identification of Active Compounds from Gami-Soyosan Toxic to MCF-7 Human Breast Adenocarcinoma Cells.
Jung MY; Seo CS; Baek SE; Lee J; Shin MS; Kang KS; Lee S; Yoo JE
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31295870
[TBL] [Abstract][Full Text] [Related]
60. Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation.
Kim WJ; Lee MY; Kim JH; Suk K; Lee WH
Cancer Lett; 2010 Oct; 296(1):35-42. PubMed ID: 20381234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
